Suppr超能文献

胃复安联合地塞米松预防妇科手术术后恶心呕吐

[Prevention of postoperative nausea and vomiting by metoclopramide combined with dexamethasone in gynecological surgery].

作者信息

Nonaka Akihiko, Suzuki Satomi, Tamaki Fumimasa, Furuya Atsushi, Abe Fumiaki, Matsukawa Takashi

机构信息

Department of Anesthesia, Yamanashi Prefectural Central Hospital, Kofu 400-8506.

出版信息

Masui. 2008 Aug;57(8):978-82.

Abstract

BACKGROUND

The authors evaluated the efficacy of a combination of dexamethasone and metoclopramide for the prophylaxis of postoperative nausea and vomiting (PONV) after gynecological abdominal surgery.

METHODS

One-hundred and seventeen patients scheduled for gynecological abdominal surgery were analyzed retrospectively. Patients were classified into three groups by anti-emetics administered; none (Group C, n = 38); metoclopramide 10 mg (Group M, n = 39); or a combination of metoclopramide 10 mg with dexamethasone 8 mg (Group MD, n = 40) at 30 to 60 minutes prior to the end of surgery. Anesthesia was induced by propofol and maintained with isoflurane-nitrous oxide inhalation and intermittent administration of fentanyl. Postoperative pain was treated with continuous subcutaneous infusion of pentazocine via a patient controlled analgesia device. PONV was assessed using a 5 rating verbal score in early (0-6 hr) and in late (6-24 hr) period.

RESULTS

The 3 groups were similar in demographic characteristics. The incidence of nausea and vomiting in early period was significantly lower in Group MD compared with Group C and Group M. Rescue anti-emetic requirements were fewer in Group MD compared with Group C. There are no severe complications.

CONCLUSIONS

A combination of metoclopramide and dexamethasone was more effective in preventing PONV compared with metoclopramide alone.

摘要

背景

作者评估了地塞米松与甲氧氯普胺联合应用对妇科腹部手术后恶心呕吐(PONV)的预防效果。

方法

对117例计划行妇科腹部手术的患者进行回顾性分析。根据手术结束前30至60分钟给予的止吐药将患者分为三组:未用药组(C组,n = 38);甲氧氯普胺10毫克组(M组,n = 39);或甲氧氯普胺10毫克与地塞米松8毫克联合组(MD组,n = 40)。麻醉诱导采用丙泊酚,维持采用异氟烷-氧化亚氮吸入及芬太尼间断给药。术后疼痛通过患者自控镇痛装置持续皮下输注喷他佐辛进行治疗。PONV采用5级语言评分在早期(0 - 6小时)和晚期(6 - 24小时)进行评估。

结果

三组患者的人口统计学特征相似。MD组早期恶心呕吐的发生率显著低于C组和M组。MD组的补救性止吐药需求少于C组。未出现严重并发症。

结论

与单独使用甲氧氯普胺相比,甲氧氯普胺与地塞米松联合应用在预防PONV方面更有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验